Article

Intramural NCI Prostate Cancer Trials: Progress Made and Insights Gleaned

Solid tumors, like those found in prostate cancer, need novel paradigms in order to assess the efficacy of therapy in patients. In this abstract, a method is proposed which is used for estimating the PSA growth and regression rate constants from serial PSA measures.

To view abstract, click here.

Related Videos
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Christine Frissora, MD | Credit: Weill Cornell
Hope on the Horizon: 2 Food Allergy Breakthroughs in 2024
4 experts are featured in this series.
4 experts are featured in this series.
© 2024 MJH Life Sciences

All rights reserved.